Infusional 5-fluorouracil in the treatment of gastrointestinal cancers: The Royal Marsden Hospital experience.
Ross
P J
PJ
Department of Medicine, Royal Marsden Hospital, London.
Webb
A
A
Cunningham
D
D
Prendiville
J
J
Norman
A R
AR
Oates
J
J
D000553:Ambulatory Care / Q000191:economics; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D001661:Biliary Tract Neoplasms / Q000188:drug therapy; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy; D004358:Drug Therapy / Q000191:economics; D004938:Esophageal Neoplasms / Q000188:drug therapy; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy*; D006801:Humans; D007262:Infusions, Intravenous; D008113:Liver Neoplasms / Q000188:drug therapy; D010190:Pancreatic Neoplasms / Q000188:drug therapy
D000964:Antimetabolites, Antineoplastic; D005472:Fluorouracil